Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | -0.66% |
|
-0.66% | -6.25% |
Jul. 01 | Reneo Pharmaceuticals, Inc.(NasdaqGM:RPHM) dropped from Russell 3000E Value Index | CI |
Jul. 01 | Reneo Pharmaceuticals, Inc.(NasdaqGM:RPHM) dropped from Russell 2000 Value Index | CI |
Business Summary
Number of employees: 8
Managers
Managers | Title | Age | Since |
---|---|---|---|
Niall O'Donnell
FOU | Founder | 51 | - |
Gregory Flesher
CEO | Chief Executive Officer | 54 | 20-12-08 |
Michael Grey
FOU | Founder | 71 | 14-09-21 |
Jennifer P. Lam
ADM | Chief Administrative Officer | - | 21-07-31 |
Michael Cruse
COO | Chief Operating Officer | 52 | 20-11-30 |
Chief Tech/Sci/R&D Officer | 64 | 17-12-31 | |
Ashley Hall
PRN | Corporate Officer/Principal | 52 | 21-10-10 |
Corporate Officer/Principal | - | 17-12-31 | |
Wendy Johnson
PRN | Corporate Officer/Principal | 72 | 16-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Grey
FOU | Founder | 71 | 14-09-21 |
Director/Board Member | 64 | 17-11-30 | |
Paul Hoelscher
BRD | Director/Board Member | 59 | 22-01-19 |
Gregory Flesher
CEO | Chief Executive Officer | 54 | 20-12-08 |
Stacey Seltzer
BRD | Director/Board Member | 47 | 20-11-30 |
Niall O'Donnell
FOU | Founder | 51 | - |
Bali Muralidhar
BRD | Director/Board Member | 44 | 21-03-31 |
Roshawn Blunt
BRD | Director/Board Member | 49 | 21-12-31 |
Eric Dube
BRD | Director/Board Member | 51 | 21-03-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 33,420,808 | 31,701,938 ( 94.86 %) | 0 | 94.86 % |
Company contact information
![address Reneo Pharmaceuticals, Inc.(RPHM)](https://cdn.zonebourse.com/static/address/121146806.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.25% | 50.13M | |
+18.97% | 45.34B | |
+42.78% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- RPHM Stock
- Company Reneo Pharmaceuticals, Inc.